[VI-antibody formation in typhoid patients treated with VI-antigen, pentoxyl and levomycetin].
D000917:Antibody Formation; D002353:Carrier State / Q000517:prevention & control; D002701:Chloramphenicol / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D007279:Injections, Subcutaneous; D014435:Typhoid Fever / Q000188:drug therapy / Q000276:immunology* / Q000517:prevention & control; D014498:Uracil / Q000627:therapeutic use*; D014611:Vaccination
D014498:Uracil; D002701:Chloramphenicol
VI-antiteloobrazovanie u bol'nykh briushnym tifom, lechennykh s primeneniem VI-antigena, pentoksila i levomitsetina.